ENLIVEX THERAPEUTICS LTD's ticker is and the CUSIP is M4130Y906. A total of 3 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,740 | +58.0% | 3,000 | +400.0% | 0.00% | – |
| Q2 2022 | $3,000 | -92.1% | 600 | -91.0% | 0.00% | – |
| Q1 2022 | $38,000 | -86.0% | 6,700 | -84.6% | 0.00% | – |
| Q4 2021 | $272,000 | +19.8% | 43,500 | +89.1% | 0.00% | – |
| Q3 2021 | $227,000 | +124.8% | 23,000 | +103.5% | 0.00% | – |
| Q2 2021 | $101,000 | +31.2% | 11,300 | +63.8% | 0.00% | – |
| Q1 2021 | $77,000 | +862.5% | 6,900 | +590.0% | 0.00% | – |
| Q4 2020 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 600 | $3,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3,100 | $14,000 | 0.00% |